Response to Comments on Nanoparticles Zinc Paste Bandages for the Treatment of Syrian Woman Diabetic Patient With Ulcers in the Foot: Case Images

Thank you for your thoughtful and constructive feedback regarding our recent article, “Nanoparticles Zinc Paste Bandages for the Treatment of a Syrian Diabetic Patient with Foot Ulcers: Case Images.” [1] We appreciate your insights, which serve to enhance the dialogue surrounding the use of nanoparticle zinc paste bandages in diabetic foot ulcer management. Omission of Concomitant Treatments and Laboratory Data: We acknowledge the importance of providing comprehensive information regarding concomitant treatments and laboratory data. In our study, we focused specifically on the use of zinc paste bandages and have now recognized that inclusion of the patient's concurrent medications and baseline laboratory parameters would present a more holistic view of the patient's health status and the treatment's effects. We will work on providing more detailed accounts of these aspects in future publications, as we had added to one of our other publications [2]. Where we work on them. Another significant consideration is that our article was categorized as a Case Image type publication. This classification imposed certain limitations on the amount of detail we could provide about various aspects of our research. Consequently, we had to adhere to strict word count restrictions, which constrained our ability to elaborate on each point thoroughly. As a result, some nuanced information that could enhance understanding may not have been included. This limitation is common in Case Image submissions, where visual representation often takes precedence over extensive written description. Peripheral Artery Disease (PAD) Considerations: Your point about the link between diabetes and peripheral artery disease is well taken. Although our case focused primarily on the wound treatment aspect, we understand that vascular assessment is critical for a complete understanding of ulcer healing. Session Frequency and Manufacturer Specifications: Clarity on the frequency of application and detailed manufacturer specifications of the nanoparticle zinc paste used is indeed vital for reproducibility. We appreciate your suggestion again. Follow-Up and Long-Term Outcomes: The absence of long-term follow-up data is a limitation that we are aware of and is a crucial component of any treatment efficacy study. We plan to conduct further follow-up assessments to understand the durability of the treatment effects and potential safety issues over time. Your recommendation underlines the importance of longitudinal studies in establishing the long-term efficacy of new treatments. Conclusion: We greatly value your insights, as they highlight areas for improvement that will enhance the relevance and applicability of our findings in clinical settings. Addressing these limitations will not only help refine our future research but will also contribute to a deeper understanding of nanoparticle applications in wound care. Thank you once again for your valuable comments. We hope to raise the rigor of our work in response to your constructive suggestions. Sincerely, The authors. Marwan Al-Raeei: conceptualization, data curation, formal analysis, funding acquisition, resources, writing – original draft, writing – review and editing. Reham Alwis: data curation, resources. Razan Alwis: data curation, resources, writing – original draft. The authors have followed all of the ethics publishing terms. Written informed consent was obtained from the patient to publish this report. The authors declare no conflicts of interest. All data are included in the manuscript.